Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2025-2031

January 2025 | 105 pages | ID: G794C221C5D2EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Anti-inflammatory Therapeutics market size is predicted to grow from US$ 121620 million in 2025 to US$ 175750 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

LPI (LP Information)' newest research report, the “Anti-inflammatory Therapeutics Industry Forecast” looks at past sales and reviews total world Anti-inflammatory Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-inflammatory Therapeutics sales for 2025 through 2031. With Anti-inflammatory Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-inflammatory Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Anti-inflammatory Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-inflammatory Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-inflammatory Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-inflammatory Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-inflammatory Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-inflammatory Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Anti-inflammatory Biologics
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Others

Segmentation by Application:

• Arthritis
• Respiratory Diseases
• Dermatology
• Gastroenterology
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AbbVie
• Johnson & Johnson
• Amgen Inc
• AstraZeneca PLC
• Pfizer, Inc
• Novartis
• Roche
• Merck
• Sanofi
• GlaxoSmithKline
• Sun Pharmaceutical Industries Ltd
• TEVA

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-inflammatory Therapeutics Market Size (2020-2031)
  2.1.2 Anti-inflammatory Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Anti-inflammatory Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Anti-inflammatory Therapeutics Segment by Type
  2.2.1 Anti-inflammatory Biologics
  2.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  2.2.3 Corticosteroids
  2.2.4 Others
2.3 Anti-inflammatory Therapeutics Market Size by Type
  2.3.1 Anti-inflammatory Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Anti-inflammatory Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Anti-inflammatory Therapeutics Segment by Application
  2.4.1 Arthritis
  2.4.2 Respiratory Diseases
  2.4.3 Dermatology
  2.4.4 Gastroenterology
  2.4.5 Others
2.5 Anti-inflammatory Therapeutics Market Size by Application
  2.5.1 Anti-inflammatory Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Anti-inflammatory Therapeutics Market Size Market Share by Application (2020-2025)

3 ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Anti-inflammatory Therapeutics Market Size Market Share by Player
  3.1.1 Global Anti-inflammatory Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Anti-inflammatory Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTI-INFLAMMATORY THERAPEUTICS BY REGION

4.1 Anti-inflammatory Therapeutics Market Size by Region (2020-2025)
4.2 Global Anti-inflammatory Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-inflammatory Therapeutics Market Size Growth (2020-2025)
4.4 APAC Anti-inflammatory Therapeutics Market Size Growth (2020-2025)
4.5 Europe Anti-inflammatory Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Anti-inflammatory Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
5.2 Americas Anti-inflammatory Therapeutics Market Size by Type (2020-2025)
5.3 Americas Anti-inflammatory Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti-inflammatory Therapeutics Market Size by Region (2020-2025)
6.2 APAC Anti-inflammatory Therapeutics Market Size by Type (2020-2025)
6.3 APAC Anti-inflammatory Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
7.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2020-2025)
7.3 Europe Anti-inflammatory Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-inflammatory Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET FORECAST

10.1 Global Anti-inflammatory Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Anti-inflammatory Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Anti-inflammatory Therapeutics Forecast
  10.1.3 APAC Anti-inflammatory Therapeutics Forecast
  10.1.4 Europe Anti-inflammatory Therapeutics Forecast
  10.1.5 Middle East & Africa Anti-inflammatory Therapeutics Forecast
10.2 Americas Anti-inflammatory Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Anti-inflammatory Therapeutics Forecast
  10.2.2 Canada Market Anti-inflammatory Therapeutics Forecast
  10.2.3 Mexico Market Anti-inflammatory Therapeutics Forecast
  10.2.4 Brazil Market Anti-inflammatory Therapeutics Forecast
10.3 APAC Anti-inflammatory Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Anti-inflammatory Therapeutics Market Forecast
  10.3.2 Japan Market Anti-inflammatory Therapeutics Forecast
  10.3.3 Korea Market Anti-inflammatory Therapeutics Forecast
  10.3.4 Southeast Asia Market Anti-inflammatory Therapeutics Forecast
  10.3.5 India Market Anti-inflammatory Therapeutics Forecast
  10.3.6 Australia Market Anti-inflammatory Therapeutics Forecast
10.4 Europe Anti-inflammatory Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Anti-inflammatory Therapeutics Forecast
  10.4.2 France Market Anti-inflammatory Therapeutics Forecast
  10.4.3 UK Market Anti-inflammatory Therapeutics Forecast
  10.4.4 Italy Market Anti-inflammatory Therapeutics Forecast
  10.4.5 Russia Market Anti-inflammatory Therapeutics Forecast
10.5 Middle East & Africa Anti-inflammatory Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Anti-inflammatory Therapeutics Forecast
  10.5.2 South Africa Market Anti-inflammatory Therapeutics Forecast
  10.5.3 Israel Market Anti-inflammatory Therapeutics Forecast
  10.5.4 Turkey Market Anti-inflammatory Therapeutics Forecast
10.6 Global Anti-inflammatory Therapeutics Forecast by Type (2026-2031)
10.7 Global Anti-inflammatory Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Anti-inflammatory Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 AbbVie
  11.1.1 AbbVie Company Information
  11.1.2 AbbVie Anti-inflammatory Therapeutics Product Offered
  11.1.3 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AbbVie Main Business Overview
  11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Information
  11.2.2 Johnson & Johnson Anti-inflammatory Therapeutics Product Offered
  11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson Latest Developments
11.3 Amgen Inc
  11.3.1 Amgen Inc Company Information
  11.3.2 Amgen Inc Anti-inflammatory Therapeutics Product Offered
  11.3.3 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Amgen Inc Main Business Overview
  11.3.5 Amgen Inc Latest Developments
11.4 AstraZeneca PLC
  11.4.1 AstraZeneca PLC Company Information
  11.4.2 AstraZeneca PLC Anti-inflammatory Therapeutics Product Offered
  11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AstraZeneca PLC Main Business Overview
  11.4.5 AstraZeneca PLC Latest Developments
11.5 Pfizer, Inc
  11.5.1 Pfizer, Inc Company Information
  11.5.2 Pfizer, Inc Anti-inflammatory Therapeutics Product Offered
  11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Pfizer, Inc Main Business Overview
  11.5.5 Pfizer, Inc Latest Developments
11.6 Novartis
  11.6.1 Novartis Company Information
  11.6.2 Novartis Anti-inflammatory Therapeutics Product Offered
  11.6.3 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Novartis Main Business Overview
  11.6.5 Novartis Latest Developments
11.7 Roche
  11.7.1 Roche Company Information
  11.7.2 Roche Anti-inflammatory Therapeutics Product Offered
  11.7.3 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Roche Main Business Overview
  11.7.5 Roche Latest Developments
11.8 Merck
  11.8.1 Merck Company Information
  11.8.2 Merck Anti-inflammatory Therapeutics Product Offered
  11.8.3 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Merck Main Business Overview
  11.8.5 Merck Latest Developments
11.9 Sanofi
  11.9.1 Sanofi Company Information
  11.9.2 Sanofi Anti-inflammatory Therapeutics Product Offered
  11.9.3 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sanofi Main Business Overview
  11.9.5 Sanofi Latest Developments
11.10 GlaxoSmithKline
  11.10.1 GlaxoSmithKline Company Information
  11.10.2 GlaxoSmithKline Anti-inflammatory Therapeutics Product Offered
  11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 GlaxoSmithKline Main Business Overview
  11.10.5 GlaxoSmithKline Latest Developments
11.11 Sun Pharmaceutical Industries Ltd
  11.11.1 Sun Pharmaceutical Industries Ltd Company Information
  11.11.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offered
  11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Sun Pharmaceutical Industries Ltd Main Business Overview
  11.11.5 Sun Pharmaceutical Industries Ltd Latest Developments
11.12 TEVA
  11.12.1 TEVA Company Information
  11.12.2 TEVA Anti-inflammatory Therapeutics Product Offered
  11.12.3 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 TEVA Main Business Overview
  11.12.5 TEVA Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Anti-inflammatoryTherapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Anti-inflammatoryTherapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anti-inflammatory Biologics
Table 4. Major Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Table 5. Major Players of Corticosteroids
Table 6. Major Players of Others
Table 7. Anti-inflammatoryTherapeutics Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Anti-inflammatoryTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 9. Global Anti-inflammatoryTherapeutics Market Size Market Share byType (2020-2025)
Table 10. Anti-inflammatoryTherapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Anti-inflammatoryTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Anti-inflammatoryTherapeutics Market Size Market Share by Application (2020-2025)
Table 13. Global Anti-inflammatoryTherapeutics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Anti-inflammatoryTherapeutics Revenue Market Share by Player (2020-2025)
Table 15. Anti-inflammatoryTherapeutics Key Players Head office and Products Offered
Table 16. Anti-inflammatoryTherapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Anti-inflammatoryTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Anti-inflammatoryTherapeutics Market Size Market Share by Region (2020-2025)
Table 21. Global Anti-inflammatoryTherapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Anti-inflammatoryTherapeutics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Anti-inflammatoryTherapeutics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Anti-inflammatoryTherapeutics Market Size Market Share by Country (2020-2025)
Table 25. Americas Anti-inflammatoryTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 26. Americas Anti-inflammatoryTherapeutics Market Size Market Share byType (2020-2025)
Table 27. Americas Anti-inflammatoryTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Anti-inflammatoryTherapeutics Market Size Market Share by Application (2020-2025)
Table 29. APAC Anti-inflammatoryTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Anti-inflammatoryTherapeutics Market Size Market Share by Region (2020-2025)
Table 31. APAC Anti-inflammatoryTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 32. APAC Anti-inflammatoryTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Anti-inflammatoryTherapeutics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Anti-inflammatoryTherapeutics Market Size Market Share by Country (2020-2025)
Table 35. Europe Anti-inflammatoryTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 36. Europe Anti-inflammatoryTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Anti-inflammatoryTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Anti-inflammatoryTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 39. Middle East & Africa Anti-inflammatoryTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Anti-inflammatoryTherapeutics
Table 41. Key Market Challenges & Risks of Anti-inflammatoryTherapeutics
Table 42. Key IndustryTrends of Anti-inflammatoryTherapeutics
Table 43. Global Anti-inflammatoryTherapeutics Market SizeForecast by Region (2026-2031) & ($ millions)
Table 44. Global Anti-inflammatoryTherapeutics Market Size Market ShareForecast by Region (2026-2031)
Table 45. Global Anti-inflammatoryTherapeutics Market SizeForecast byType (2026-2031) & ($ millions)
Table 46. Global Anti-inflammatoryTherapeutics Market SizeForecast by Application (2026-2031) & ($ millions)
Table 47. AbbVie Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 48. AbbVie Anti-inflammatoryTherapeutics Product Offered
Table 49. AbbVie Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. AbbVie Main Business
Table 51. AbbVie Latest Developments
Table 52. Johnson & Johnson Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 53. Johnson & Johnson Anti-inflammatoryTherapeutics Product Offered
Table 54. Johnson & Johnson Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Johnson & Johnson Main Business
Table 56. Johnson & Johnson Latest Developments
Table 57. Amgen Inc Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 58. Amgen Inc Anti-inflammatoryTherapeutics Product Offered
Table 59. Amgen Inc Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Amgen Inc Main Business
Table 61. Amgen Inc Latest Developments
Table 62. AstraZeneca PLC Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 63. AstraZeneca PLC Anti-inflammatoryTherapeutics Product Offered
Table 64. AstraZeneca PLC Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. AstraZeneca PLC Main Business
Table 66. AstraZeneca PLC Latest Developments
Table 67. Pfizer, Inc Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 68. Pfizer, Inc Anti-inflammatoryTherapeutics Product Offered
Table 69. Pfizer, Inc Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Pfizer, Inc Main Business
Table 71. Pfizer, Inc Latest Developments
Table 72. Novartis Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 73. Novartis Anti-inflammatoryTherapeutics Product Offered
Table 74. Novartis Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Novartis Main Business
Table 76. Novartis Latest Developments
Table 77. Roche Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 78. Roche Anti-inflammatoryTherapeutics Product Offered
Table 79. Roche Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Roche Main Business
Table 81. Roche Latest Developments
Table 82. Merck Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 83. Merck Anti-inflammatoryTherapeutics Product Offered
Table 84. Merck Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Sanofi Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 88. Sanofi Anti-inflammatoryTherapeutics Product Offered
Table 89. Sanofi Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. GlaxoSmithKline Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 93. GlaxoSmithKline Anti-inflammatoryTherapeutics Product Offered
Table 94. GlaxoSmithKline Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. GlaxoSmithKline Main Business
Table 96. GlaxoSmithKline Latest Developments
Table 97. Sun Pharmaceutical Industries Ltd Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 98. Sun Pharmaceutical Industries Ltd Anti-inflammatoryTherapeutics Product Offered
Table 99. Sun Pharmaceutical Industries Ltd Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Sun Pharmaceutical Industries Ltd Main Business
Table 101. Sun Pharmaceutical Industries Ltd Latest Developments
Table 102.TEVA Details, CompanyType, Anti-inflammatoryTherapeutics Area Served and Its Competitors
Table 103.TEVA Anti-inflammatoryTherapeutics Product Offered
Table 104.TEVA Anti-inflammatoryTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105.TEVA Main Business
Table 106.TEVA Latest Developments



LIST OFFIGURES

Figure 1. Anti-inflammatoryTherapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-inflammatoryTherapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Anti-inflammatoryTherapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Anti-inflammatoryTherapeutics Sales Market Share by Country/Region (2024)
Figure 8. Anti-inflammatoryTherapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Anti-inflammatoryTherapeutics Market Size Market Share byType in 2024
Figure 10. Anti-inflammatoryTherapeutics in Arthritis
Figure 11. Global Anti-inflammatoryTherapeutics Market: Arthritis (2020-2025) & ($ millions)
Figure 12. Anti-inflammatoryTherapeutics in Respiratory Diseases
Figure 13. Global Anti-inflammatoryTherapeutics Market: Respiratory Diseases (2020-2025) & ($ millions)
Figure 14. Anti-inflammatoryTherapeutics in Dermatology
Figure 15. Global Anti-inflammatoryTherapeutics Market: Dermatology (2020-2025) & ($ millions)
Figure 16. Anti-inflammatoryTherapeutics in Gastroenterology
Figure 17. Global Anti-inflammatoryTherapeutics Market: Gastroenterology (2020-2025) & ($ millions)
Figure 18. Anti-inflammatoryTherapeutics in Others
Figure 19. Global Anti-inflammatoryTherapeutics Market: Others (2020-2025) & ($ millions)
Figure 20. Global Anti-inflammatoryTherapeutics Market Size Market Share by Application in 2024
Figure 21. Global Anti-inflammatoryTherapeutics Revenue Market Share by Player in 2024
Figure 22. Global Anti-inflammatoryTherapeutics Market Size Market Share by Region (2020-2025)
Figure 23. Americas Anti-inflammatoryTherapeutics Market Size 2020-2025 ($ millions)
Figure 24. APAC Anti-inflammatoryTherapeutics Market Size 2020-2025 ($ millions)
Figure 25. Europe Anti-inflammatoryTherapeutics Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Anti-inflammatoryTherapeutics Market Size 2020-2025 ($ millions)
Figure 27. Americas Anti-inflammatoryTherapeutics Value Market Share by Country in 2024
Figure 28. United States Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Anti-inflammatoryTherapeutics Market Size Market Share by Region in 2024
Figure 33. APAC Anti-inflammatoryTherapeutics Market Size Market Share byType (2020-2025)
Figure 34. APAC Anti-inflammatoryTherapeutics Market Size Market Share by Application (2020-2025)
Figure 35. China Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. India Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Anti-inflammatoryTherapeutics Market Size Market Share by Country in 2024
Figure 42. Europe Anti-inflammatoryTherapeutics Market Size Market Share byType (2020-2025)
Figure 43. Europe Anti-inflammatoryTherapeutics Market Size Market Share by Application (2020-2025)
Figure 44. Germany Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45.France Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Anti-inflammatoryTherapeutics Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Anti-inflammatoryTherapeutics Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa Anti-inflammatoryTherapeutics Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Anti-inflammatoryTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 58. APAC Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 59. Europe Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 61. United States Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 62. Canada Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 63. Mexico Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 64. Brazil Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 65. China Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 66. Japan Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 67. Korea Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 69. India Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 70. Australia Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 71. Germany Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 72.France Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 73. UK Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 74. Italy Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 75. Russia Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 76. Egypt Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 77. South Africa Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 78. Israel Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 79.Turkey Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)
Figure 80. Global Anti-inflammatoryTherapeutics Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global Anti-inflammatoryTherapeutics Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries Anti-inflammatoryTherapeutics Market Size 2026-2031 ($ millions)